172405-14-0

Basic information

• Product Name: Carbamic acid, (1,2-dihydro-2-oxo-4-pyrimidinyl)-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, (1,2-dihydro-2-oxo-4-pyrimidinyl)-, 1,1-dimethylethyl ester (9CI)
• CAS NO: 172405-14-0
• Molecular Formula: C₉H₁₃N₃O₃
• Molecular Weight: 211.21782
• Product Categories: N-BOC
• Mol File: 172405-14-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, (1,2-dihydro-2-oxo-4-pyrimidinyl)-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (1,2-dihydro-2-oxo-4-pyrimidinyl)-, 1,1-dimethylethyl ester (9CI)(172405-14-0)
• EPA Substance Registry System: Carbamic acid, (1,2-dihydro-2-oxo-4-pyrimidinyl)-, 1,1-dimethylethyl ester (9CI)(172405-14-0)

Safety Data

• Hazardous Substances Data: 172405-14-0(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 71-30-7 Cytosine 

Downstream Products

• 236755-62-7 L-serine, O-[[4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-1(2H)-pyrimidinyl]methyl]-N-[(9H-fluoren-9-ylmethoxy)-carbonyl]-phenylmethyl ester 
• 854596-32-0 C₃₂H₃₅N₃O₅ 

Relevant articles and documents

Prodrug composition

A prodrug composition is provided which includes a pharmaceutical species and an amino acid having a covalent bond to the pharmaceutical species. The pharmaceutical species is characterized by bioavailability of 30% or less and a molecular weight in the r

Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids

There are described N-ethylglycine derivatives of the formula I in which PG is a urethane-type or trityl-type amino protective group which is labile to weak acids, X is NH, O or S, Y is CH2, NH or O, and B' are bases customary in nucleotide chemistry, the exocyclic amino or hydroxyl groups of which being protected by suitable, known protective groups, or are base substitute compounds, and their salts with tert-organic bases, as well as a process for their preparation. The N-ethylglycine derivatives of the formula I are used in the preparation of PNA and PNA/DNA hybrids.